Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2025-12-28 @ 7:14 PM
Study NCT ID:
NCT00720304
Status:
COMPLETED
Last Update Posted:
2024-08-22
First Post:
2008-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Case Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE5307
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None